DURAND REMY 4
4 · ALPINE IMMUNE SCIENCES, INC. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
DURAND REMY
Chief Business Officer
Transactions
- Award
Common Stock
2024-01-04+31,200→ 38,104 total - Award
Stock Option (Right to buy)
2024-01-04+78,000→ 78,000 totalExercise: $18.33Exp: 2034-01-03→ Common Stock (78,000 underlying)
Footnotes (3)
- [F1]Received grant of restricted stock units ("RSUs") for no consideration. One-fourth (1/4th) of the RSUs will vest on January 1, 2025 and the remainder will vest in twelve (12) equal quarterly installments on April 1, 2025 July 1, 2025, October 1, 2025 and on January 1, April 1, July 1, and October 1 of each subsequent year until all RSUs are vested on January 1, 2028, subject to the Reporting Person continuing to be a Service Provider through each such date.
- [F2]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F3]One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2025, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.